News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,596 Results
Type
Article (87728)
Company Profile (824)
Press Release (778025)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (233164)
Career Advice (4143)
Deals (39830)
Drug Delivery (144)
Drug Development (91346)
Employer Resources (203)
FDA (18347)
Job Trends (17414)
News (397679)
Policy (39946)
Tag
Academia (3006)
Academic (2)
Accelerated approval (25)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (166)
Alzheimer's disease (1755)
Antibody-drug conjugate (ADC) (301)
Approvals (18436)
Artificial intelligence (576)
Autoimmune disease (128)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (186)
Biotechnology (488)
Bladder cancer (149)
Brain cancer (61)
Breast cancer (593)
Cancer (4614)
Cardiovascular disease (405)
Career advice (3565)
Career pathing (40)
CAR-T (288)
CDC (59)
Celiac Disease (1)
Cell therapy (780)
Cervical cancer (36)
Clinical research (76439)
Collaboration (1573)
Company closure (5)
Compensation (1055)
Complete response letters (65)
COVID-19 (2974)
CRISPR (93)
C-suite (726)
Cystic fibrosis (147)
Data (5726)
Decentralized trials (2)
Denatured (68)
Depression (131)
Diabetes (490)
Diagnostics (7160)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (266)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (221)
Earnings (99873)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134454)
Executive appointments (1009)
FDA (21156)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1424)
Gene editing (201)
Generative AI (59)
Gene therapy (616)
GLP-1 (1080)
Government (5417)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (271)
Immuno-oncology (34)
Indications (73)
Infectious disease (3242)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (214)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (642)
Lymphoma (357)
Machine learning (40)
Management (66)
Manufacturing (735)
MASH (164)
Medical device (14963)
Medtech (15002)
Mergers & acquisitions (22860)
Metabolic disorders (1274)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (320)
Neuropsychiatric disorders (85)
Neuroscience (2938)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (608)
Opinion (325)
Ovarian cancer (152)
Pain (183)
Pancreatic cancer (198)
Parkinson's disease (269)
Partnered (34)
Patents (462)
Patient recruitment (393)
Peanut (58)
People (66604)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23605)
Phase II (33182)
Phase III (24999)
Pipeline (3748)
Policy (318)
Postmarket research (3554)
Preclinical (10656)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (794)
Real estate (7435)
Recruiting (80)
Regulatory (28491)
Reports (65)
Research institute (2714)
Resumes & cover letters (651)
Rett syndrome (23)
RNA editing (16)
RSV (82)
Schizophrenia (147)
Series A (232)
Series B (177)
Service/supplier (30)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (116)
Vaccines (1099)
Venture capital (76)
Weight loss (427)
Women's health (76)
Worklife (21)
Date
Today (121)
Last 7 days (659)
Last 30 days (2792)
Last 365 days (33371)
2025 (32132)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (85)
Alaska (7)
Arizona (324)
Arkansas (14)
Asia (51287)
Australia (9013)
California (10730)
Canada (3145)
China (1037)
Colorado (452)
Connecticut (478)
Delaware (320)
Europe (117902)
Florida (1572)
Georgia (348)
Hawaii (3)
Idaho (68)
Illinois (884)
India (62)
Indiana (516)
Iowa (22)
Japan (373)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1394)
Massachusetts (7958)
Michigan (339)
Minnesota (623)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2937)
New Mexico (32)
New York (2872)
North Carolina (1526)
North Dakota (10)
Northern California (5044)
Ohio (326)
Oklahoma (22)
Oregon (52)
Pennsylvania (2177)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4121)
Tennessee (165)
Texas (1680)
United States (39068)
Utah (323)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (903)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
There are 866,596 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Azenta Authorizes $250 Million Share Repurchase Program
December 11, 2025
·
2 min read
Press Releases
Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
December 11, 2025
·
5 min read
Press Releases
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
December 11, 2025
·
6 min read
Press Releases
Privo Technologies Begins Dosing PRV131 in Arm 3 Of Clinical Study CLN-004, A First-In-Class Cisplatin Intratumoral Injectable Targeting Oral Cavity Cancer
December 11, 2025
·
3 min read
Press Releases
Intuitive Announces Expanded Indications for da Vinci SP
December 11, 2025
·
3 min read
Press Releases
DLH Reports Fiscal 2025 Fourth Quarter Results
December 11, 2025
·
11 min read
Press Releases
GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
December 11, 2025
·
12 min read
Press Releases
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
December 11, 2025
·
6 min read
Press Releases
BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS)
December 11, 2025
·
7 min read
Press Releases
Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome
December 11, 2025
·
7 min read
1 of 86,660
Next
